ClinicalTrials.Veeva

Menu
O

OK Clinical Research | Edmond, OK

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Dupilumab
SAR443765
Verekitug
Lunsekimig
UPB-101
Astegolimab
Amlitelimab
Atogepant
Rocatinlimab
Olodaterol

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 40 total trials

A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT st...

Active, not recruiting
Severe Asthma
Drug: Verekitug
Drug: Placebo
Recently updated

This is a long-term safety study to evaluate the safety and tolerability of intermittent use of elismetrep in the acute treatment of migraine attacks.

Enrolling
Acute Migraine
Drug: Elismetrep

A Randomized, Double-blind, Placebo-controlled, Multiple Dose-Ranging Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic...

Active, not recruiting
COPD
Other: Placebo
Biological: Biological: Solrikitug high dose
Recently updated

This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with plac...

Enrolling
Migraine
Drug: Placebo
Drug: Elismetrep

The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmo...

Active, not recruiting
Chronic Obstructive Pulmonary Disease
Drug: Astegolimab

This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, PK, and immunogenicity of APG777 in a...

Active, not recruiting
Asthma
Drug: Placebo
Drug: APG777

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of...

Enrolling
Asthma
Other: Placebo
Drug: PF-07275315

This is a phase 2, open-label extension study to evaluate the long-term safety and efficacy of lunsekimig in adult participants with asthma who have...

Invitation-only
Asthma
Drug: Lunsekimig

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this study is...

Active, not recruiting
Asthma
Drug: Budesonide/Albuterol
Drug: Lunsekimig

Trial sponsors

Sanofi logo
Pfizer logo
Allergan logo
K
Roche logo
U
T
U
AbbVie logo
Amgen logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems